Identification and functional characterization of a novel fungal immunomodulatory protein from Postia placenta

Shu Ying Li1, Li Jun Shi2, Yang Ding1

  • 1Institute of Agro-products Processing Science and Technology, Chinese Academy of Agricultural Sciences (CAAS), Key Laboratory of Agro-products Processing, Ministry of Agriculture, No. 2 Yuan Ming Yuan West Road, Beijing 100193, China.

Insights

A novel fungal immunomodulatory protein (FIP), FIP-ppl, was discovered in Postia placenta. This protein shows potential therapeutic applications, stimulating immune cells and inhibiting tumor growth.

Area of Science:

  • Mycology
  • Immunology
  • Biochemistry

Background:

  • Fungal immunomodulatory proteins (FIPs) are bioactive compounds with diverse biological activities.
  • Identification of FIPs has primarily focused on edible macro fungi.
  • Exploring non-edible fungi offers potential for novel FIP discovery.

Purpose of the Study:

  • To identify and characterize a novel fungal immunomodulatory protein (FIP) from the basidiomycete fungus Postia placenta.
  • To investigate the biological activities of the recombinant FIP-ppl, including hemagglutination, immunomodulation, and antitumor effects.
  • To establish an efficient method for the identification, production, and isolation of new FIPs.

Main Methods:

  • Genome mining using known FIPs as probes to identify the FIP-ppl gene.
  • Gene synthesis and expression in Escherichia coli to produce a glutathione S-transferase (GST) fusion protein.
  • Purification of the recombinant protein (rFIP-ppl) using GST affinity chromatography and thrombin cleavage.
  • Assays for hemagglutination, splenocyte proliferation, interleukin-2 release, and antitumor activity against human tumor cell lines.

Main Results:

  • A novel FIP, FIP-ppl, was identified from Postia placenta, marking the first basidiomycete FIP outside edible macro fungi.
  • Recombinant FIP-ppl exhibited hemagglutination activity against rabbit red blood cells.
  • rFIP-ppl stimulated mouse splenocyte proliferation and enhanced interleukin-2 (IL-2) release.
  • rFIP-ppl demonstrated significant inhibition of human tumor cell proliferation and induced apoptosis, with greater efficacy against gastric cancer cells (MGC823) than hepatoma cells (HepG2).

Conclusions:

  • This study presents an effective strategy for discovering and producing novel FIPs from fungal genomes.
  • FIP-ppl possesses immunomodulatory and antitumor properties, suggesting potential therapeutic applications.
  • The findings open avenues for exploring non-edible fungi as sources of novel bioactive compounds for human health.

Related Concept Videos